Blog Articles

FDA approves Rizafilm, the first oral thin film using IntelGenx proprietary drug delivery technology, for the acute treatment of migraine with or without aura.

The prescription wearable neuromodulation device, Nerivio, was recently cleared by the FDA for preventive treatment of migraine.

Struggles to get to the clinic? Trying to reduce your exposure to COVID-19? Telehealth is safe and easy — receive quality care from anywhere. If you live in Illinois, California, or Florida we could see you via our secure telehealth platform.

FDA has approved a new nasal spray for acute treatment of migraine in adults.

A brief discussion about a balanced approach to migraine treatment that may include lifestyle modifications, medications, and the state-of-the-art approved neuromodulation devices that may help treat and prevent migraine attacks.

Dr. Alex's interview with MassDevice medical network about novel options in migraine management: CGRP active drugs and non-invasive neuromodulation devices approved for migraine treatment.

Here Dr. Alex Feoktistov discusses migraine symptoms and diagnosis as well acute and prophylactic treatment options.

This is the first episode of our three-part special on headaches with renowned headache specialist Alexander Feoktistov MD, PhD. Dr. Feoktistov discusses common causes of headaches, process of correct diagnosis, and types of headaches.

This is an article from the Midtown Athletic Club website referring to another success story when identifying a connection between the spine, neck pain and migraine can dramatically change the outcome!

There are situations when you may wake up with a headache. Here is a quick look at the contributing factors.

Easy to listen to podcast on: What is the difference between tension headaches and migraines in teens. What are some common symptoms of migraines in teens – and does it differ from migraine symptoms for adults? What are the different migraine types?

What are the common migraine symptoms and which treatment options are available today?

Non-pharmacologic options for teens with migraine.

About 28% of teens between 15-19 years suffer from migraine headaches. It appears that stress is a common trigger (and not only for adolescents). Effective pharmacological and non-pharmacological treatment options should be considered.